Coverage
-
May 04, 2021
Amphastar Pharmaceuticals Inc. must pay Sanofi-Aventis $17.2 million in attorney fees, expenses and interest in its failed False Claims Act suit against the company's predecessor alleging the blood thinner Lovenox was improperly patented, a California federal judge ruled Monday.
11 other articles on this case.
View all »